Fundraising FoxKU Leuven Research & Development
Venture capitalPre-Seed
Find your way into KU Leuven Research & Development
Sign up to see every warm intro you have to KU Leuven Research & Development
- Paths you didn't know you had: your email and LinkedIn already hold routes to the KU Leuven Research & Development team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
CD3 combines drug discovery expertise with investment activity, focusing on translating innovative science from academic and biotech partners into new medicines. It collaborates with academic researchers and biotech/pharma companies on drug discovery projects, and invests in drug discovery spin-offs and biotechs. The fund aims to bridge the gap between early biomedical research and the pharmaceutical industry, creating value for all stakeholders while addressing significant unmet medical needs.
Source: firm website, verified Jul 30, 2026.
What they invest in
from 1 of 1 portfolio companiesAI & Machine Learning ×1Biotech ×1Medical Devices ×1
Investments · 1 tracked
founders shown can be your intro path
Enedra analyzes tumor evolution patterns by decoding convergent genomic signatures from cancer genomic data.
AI & Machine LearningBiotechMedical Devices
Co-investorsDeep Science VenturesO2h Ventures
Frequently asked questions
- What stage does KU Leuven Research & Development invest at?
- KU Leuven Research & Development invests at the Pre-Seed stage.
- What sectors does KU Leuven Research & Development focus on?
- KU Leuven Research & Development focuses on Biotech, Healthtech, Medical Devices.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.